PHYA Antibody refers to antibodies specifically targeting phytochrome A (PHYA), a photoreceptor protein critical for mediating plant responses to light. PHYA is a light-labile type I phytochrome predominantly involved in far-red (FR) and red (R) light signaling, regulating processes such as de-etiolation, flowering, and photomorphogenesis . Antibodies against PHYA are widely used to study its expression, localization, and post-translational modifications in plant systems, particularly in Arabidopsis thaliana .
Immunogen: Synthetic peptides or recombinant proteins derived from conserved regions of PHYA. For example, the Agrisera antibody (AS07 220) uses a KLH-conjugated peptide from Arabidopsis PHYA (UniProt: P14712) .
Cross-reactivity: Validated in Arabidopsis thaliana, tobacco, and peanut . Other variants, such as the Cepham Life Sciences antibody (P34752), target phytase A (PHYA) from Aspergillus niger .
PHYA exists in two interconvertible forms: the R light–absorbing Pr form and the FR light–absorbing Pfr form. Monoclonal antibodies like mAP20 and mAR07 show preferential binding to Pr and Pfr conformations, respectively .
PHYA mediates rapid R light–induced phosphorylation of downstream signaling components like FAR-RED ELONGATED HYPOCOTYL1 (FHY1) and FHY1-LIKE (FHL), which regulate PHYA nuclear accumulation .
Phosphorylation of FHY1 is R/FR reversible and dependent on PHYA activity .
Ubiquitylation of PHYA at lysine residues (K65, K92, K143, K206, K603, K942) facilitates its proteasomal degradation under light conditions .
Mutations in the hinge region (e.g., S590A, T593A, S602A) disrupt PHYA phosphorylation, reducing its ability to interact with COP1-SPA complexes and impairing photomorphogenesis .
Phosphorylated PHYA forms are critical for FR light responses; mutants lacking phosphorylation (e.g., phyA-105, phyA-300D) exhibit defective light signaling .
PHYA directly binds FHY1/FHL via its Pfr form, promoting their nuclear translocation .
PHYA inhibits COP1–SPA1 interactions in a light-dependent manner, modulating HY5 protein levels and photomorphogenesis .
Phytochrome A (phyA) is a regulatory photoreceptor existing in two forms: the Pr form absorbing maximally in the red region of the spectrum and the Pfr form absorbing maximally in the far-red region. The photoconversion of Pr to Pfr triggers various morphogenetic responses, while the reconversion of Pfr to Pr cancels these responses. Pfr controls the expression of numerous nuclear genes, including those encoding the small subunit of ribulose-bisphosphate carboxylase, chlorophyll A/B binding protein, protochlorophyllide reductase, rRNA, etc. It also negatively regulates its own gene expression. PhyA plays a role in regulating flowering time. In red light conditions, phyA can phosphorylate FHY1 and possibly FHL, inactivating their co-shuttling to the nucleus. PhyA regulates phototropic responses both in the nucleus (e.g., hypocotyl elongation and cotyledon opening under high-irradiance conditions and seed germination under very-low-fluence conditions) and in the cytoplasm (e.g., negative gravitropism in blue light and red-enhanced phototropism).
Here’s a structured FAQ for PHYA (Phytochrome A) antibodies tailored to academic research scenarios, incorporating methodological rigor and scientific depth:
Integrated methodology:
Perform subcellular fractionation followed by Western blotting to isolate nuclear/cytoplasmic compartments .
Use confocal microscopy with organelle-specific markers (e.g., DAPI for nuclei, ER-Tracker for cytoplasm) .
Analyze phosphorylation status: PHYA nuclear translocation is often phosphorylation-dependent .
Computational and experimental:
Perform epitope mapping (e.g., phage display) to identify conserved regions across species .
Use chimeric antibodies with species-matched Fc domains to enhance compatibility (e.g., Arabidopsis PHYA antibody reformatted for rice) .
Validate via homology modeling (e.g., SWISS-MODEL) to predict antibody-antigen docking .
Biophysical approaches:
| Promoter Type | Use Case | Example | Trade-offs |
|---|---|---|---|
| Constitutive (35S) | Overexpression studies | CaMV 35S | May cause pleiotropic effects |
| Inducible (GR/LhG4) | Temporal PHYA activation | Glucocorticoid | Requires dexamethasone application |
| Tissue-specific (Lhcb) | Leaf-specific knockdown | Lhcb1*1 | Limited to photosynthetic tissues |
| Technique | Purpose | Sensitivity | Throughput |
|---|---|---|---|
| Western blot | Size confirmation | 1–10 ng | Low |
| ELISA | Quantification | 0.1–1 ng | High |
| Immunoprecipitation | Protein interaction validation | 10–100 ng | Medium |
Scenario: Discrepancies in PHYA-mediated flowering time results.